{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:30:57Z","timestamp":1758634257784},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ijantimicag.2007.07.036","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T11:17:25Z","timestamp":1193224645000},"page":"122-126","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S2","title":["Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics"],"prefix":"10.1016","volume":"30","author":[{"given":"Michael R.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.07.036_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00006454-200002000-00002","article-title":"Bacteriologic and clinical efficacy of amoxicillin\/clavulanate vs azithromycin in acute otitis media","volume":"19","author":"Dagan","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of \u03b2-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib3","first-page":"505","article-title":"Anti-infective pharmacodynamics \u2013 maximizing efficacy, minimizing toxicity","volume":"1","author":"Jacobs","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.otohns.2003.12.003","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"130","author":"Anon","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0732-8893(96)00135-6","article-title":"The Alexander Project Group. Results of the Alexander Project: a continuing multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens","volume":"25","author":"Gr\u00fcneberg","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project Group. The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/dki297","article-title":"The Alexander Project: the benefits from a decade of surveillance","volume":"56","author":"Felmingham","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0149-2918(01)80061-8","article-title":"The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin\/clavulanate","volume":"23","author":"Kaye","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.inf.0000164794.50281.1a","article-title":"Large dosage amoxicillin\/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children","volume":"24","author":"Hoberman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2007.07.036_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00006454-200109000-00002","article-title":"Bacteriologic and clinical efficacy of high dose amoxicillin\/clavulanate in children with acute otitis media","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr Infect Dis J"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T23:39:52Z","timestamp":1556926792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907004244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":10,"alternative-id":["S0924857907004244"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.07.036","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}